The multiplexing capability of the UltraSEEK® chemistry makes it easy to detect over 100 variants, including insertions and deletions, using cfDNA from a single blood draw.
Learn MoreThe VeriDose Core Panel targets the most relevant variants in 16 key genes implicated in drug metabolism pathways. It provides genotype information for 85 SNPs/INDELs recommended by leading societies for pharmacogenetics analysis (Tier 1 and Tier 2). Foundational PGx content in a single, targeted panel.
Learn MoreDate: November 19, 2024 - November 23, 2024
Location: Vancouver, Canada
29 November 2021
14 September 2021